本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Oric Pharmaceuticals Inc.

12.04
-0.0300-0.25%
成交量:106.30萬
成交額:1,284.98萬
市值:12.46億
市盈率:-8.91
高:12.41
開:12.26
低:12.00
收:12.07
52周最高:14.93
52周最低:7.23
股本:1.04億
流通股本:8,868.67萬
量比:0.96
換手率:1.20%
股息:- -
股息率:- -
每股收益(TTM):-1.3513
每股收益(LYR):-1.4747
淨資產收益率:-39.80%
總資產收益率:-25.97%
市淨率:3.27
市盈率(LYR):-8.16

資料載入中...

2026/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/04

重要事件披露

Form 8-K - Current report
2026/07/30

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/23

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/12

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/04

重要事件披露

Form 8-K - Current report
2026/04/01

重要事件披露

Form 8-K - Current report
2026/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/24

重要事件披露

Form 8-K - Current report
2026/02/23

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/23

重要事件披露

Form 8-K - Current report